SEARCH
 

PRESS

Session Information

Home ▶ Program ▶ Session Information ▶ ATS 2020 Virtual Preview: Clinical Trials Session
ATS 2020 Virtual Preview: Clinical Trials Session

 

In case you missed it, here’s the “Breaking News: Clinical Trial Results in Pulmonary Medicine” session, featuring late-breaking information on leading clinical trials affecting the pulmonary, critical care, and sleep community. This session, along with many other symposia and programs will be part of the session lineup available at ATS 2020 Virtual.


Program Lineup


Welcome and Introduction by the Chair
MeiLan K. Han, MD, MS, Ann Arbor, MI

Inhaled Triple Therapy at Two Glucocorticoid Doses in Moderate-to-Very Severe COPD: The ETHOS Study
Klaus F. Rabe, MD, PhD, Grossensdorf, Germany

Questions/Answers
Facilitator: MeiLan K. Han, MD, MS, Ann Arbor, MI

Phase 2 Randomized Controlled Trial of DPP1 Inhibitor Brensocatib (INS1007) in Patients with Bronchiectasis: the WILLOW Study
James D. Chalmers, MD, ChB, PhD, Dundee, United Kingdom

Questions/Answers
Facilitator: Jennifer L. Taylor-Cousar, MD, MSc, ATSF, Denver, CO

Inhaled Treprostinil in Interstitial Lung Disease Associated Pulmonary Hypertension: The INCREASE Study
Steven D. Nathan, MD, Falls Church, VA

Questions/Answers
Facilitator: Martin R.J. Kolb, PhD, MD, Hamilton, Canada

Sotatercept for the Treatment of Pulmonary Arterial Hypertension
David B. Badesch, MD, Aurora, CO

Questions/Answers
Facilitator: Steven M. Kawut, MD, MS, ATSF, Philadelphia, PA

Thank you and Adjournment
MeiLan K. Han, MD, MS, Ann Arbor, MI